Preliminary safety and efficacy report of a randomized trial of alemtuzumab vs chlorambucil as front-line therapy in 297 patients with progressive B-cell chronic lymphocytic leukemia.

被引：2
|
作者：
Hillmen, P
Skotnicki, AB
Robak, T
Mayer, J
Jaksic, B
Vukovic, V
Weitman, S
机构：
[1] Leeds Gen Infirm, PL-90131 Wakefield, England
[2] Jagiellonian Univ, Krakow, Poland
[3] Med Univ Lodz, Lodz, Poland
[4] Univ Hosp Brno, Brno, Czech Republic
[5] Univ Zagreb, Clin Hosp Merkur, Zagreb, Croatia
[6] Ilex Pharmaceut LP, San Antonio, TX USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2505.2505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2505
引用
收藏
页码：687A / 687A
页数：1
相关论文
共 50 条
  • [1] Preliminary phase III efficacy and safety of alemtuzumab vs chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
    Hillmen, P.
    Skotnicki, A.
    Robak, T.
    Jaksic, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 339S - 339S
  • [2] Interim safety summary of alemtuzumab vs. chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
    Robak, T
    Skotnicki, AB
    Mayer, J
    Vukovic, V
    Weitman, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 573S - 573S
  • [3] Cytogenetic correlation with efficacy on alemtuzumab (CAM) vs chlorambucil (CHLO) as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
    Dmoszynska, A.
    Fetni, R.
    Wang, Y.
    Belkaci, M.
    Sirard, C.
    Goldberg, M.
    Mayer, J.
    Robak, T.
    Skotnicki, A.
    Hillmen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 361S - 361S
  • [4] Progression free survival is superior with alemtuzumab vs chlorambucil as front-line therapy for patients with B-cell chronic lymphocytic leukemia
    Hillmen, P.
    Skotnicki, A.
    Robak, T.
    Jaksic, B.
    Sirard, C.
    Mayer, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 45 - 46
  • [5] Phase III study to evaluate the efficacy and safety of front-line therapy with alemtuzumab (CAMPATH®, MABCAMPATH®) vs. chlorambucil in patients with progressive B-cell chronic lymphocytic leukemia (CAM307).
    Skotnicki, AB
    Robak, T
    Mayer, J
    Craig, A
    Weitman, S
    BLOOD, 2003, 102 (11) : 439A - 439A
  • [6] Alemtuzumab (CAMPATH®,MABCAMPATH®) has superior progression free survival (PFS) vs chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
    Hillmen, Peter
    Skotnicki, Aleksander
    Robak, Tadeusz
    Jaksic, Branimir
    Sirard, Cynthia
    Mayer, Jiri
    BLOOD, 2006, 108 (11) : 93A - 93A
  • [7] EFFICACY AND SAFETY OF CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY AND/OR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. A GIMEMA RETROSPECTIVE STUDY
    Laurenti, L.
    Autore, F.
    Innocenti, I.
    Vannata, B.
    Ciolli, S.
    Mauro, F. R.
    Mannina, D.
    Del Poeta, G.
    D'Arena, G.
    Massaia, M.
    Coscia, M.
    Molica, S.
    Pozzato, G.
    Marasca, R.
    Galieni, P.
    Cuneo, A.
    Orlando, S.
    Piciocchi, A.
    Boncompagni, R.
    Vincelli, D.
    Liberati, A. M.
    Russo, F.
    Foa, R.
    HAEMATOLOGICA, 2015, 100 : 134 - 134
  • [8] Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia
    Mabed, M
    Aref, S
    Fouda, M
    El-Sharawy, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (10) : 2029 - 2035
  • [9] FRONT-LINE THERAPY WITH CHLORAMBUCIL PLUS RITUXIMAB IN ELDERLY AND/OR UNFIT PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA
    Innocenti, I.
    Tarnani, M.
    Vannata, B.
    De Padua, L.
    Santini, F.
    Marietti, S.
    Za, T.
    Bellesi, S.
    Autore, F.
    Chiusolo, P.
    Sora, F.
    Sica, S.
    Leone, G.
    Laurenti, L.
    HAEMATOLOGICA, 2012, 97 : 523 - 524
  • [10] Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience
    Laurenti, Luca
    Vannata, Barbara
    Innocenti, Idanna
    Autore, Francesco
    Santini, Francesco
    Piccirillo, Nicola
    Za, Tommaso
    Bellesi, Silvia
    Marietti, Sara
    Sica, Simona
    Efremov, Dimitar G.
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2013, 5 (01):
12345